These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28506860)

  • 1. Characterization of Late Recurrence After Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients.
    Soria F; Moschini M; Wirth GJ; Gust KM; Klatte T; Briganti A; Gontero P; Abufaraj M; Özsoy M; Karakiewicz PI; Shariat SF
    Urology; 2017 Aug; 106():119-124. PubMed ID: 28506860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late Recurrence of Bladder Cancer following Radical Cystectomy: Characteristics and Outcomes.
    Yoo SH; Kim H; Kwak C; Kim HH; Jung JH; Ku JH
    Urol Int; 2019; 103(3):291-296. PubMed ID: 31461728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late recurrence after radical cystectomy: patterns, risk factors and outcomes.
    Linder BJ; Boorjian SA; Hudolin T; Cheville JC; Thapa P; Tarrell RF; Frank I
    J Urol; 2014 May; 191(5):1256-61. PubMed ID: 24333110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy.
    Mitra AP; Alemozaffar M; Harris BN; Schuckman AK; Skinner EC; Daneshmand S
    Urology; 2014 Dec; 84(6):1420-6. PubMed ID: 25306479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder.
    Novotny V; Froehner M; May M; Protzel C; Hergenröther K; Rink M; Chun FK; Fisch M; Roghmann F; Palisaar RJ; Noldus J; Gierth M; Fritsche HM; Burger M; Sikic D; Keck B; Wullich B; Nuhn P; Buchner A; Stief CG; Vallo S; Bartsch G; Haferkamp A; Bastian PJ; Hakenberg OW; Propping S; Aziz A
    World J Urol; 2015 Nov; 33(11):1753-61. PubMed ID: 25663359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience.
    Moschini M; Karnes RJ; Sharma V; Gandaglia G; Fossati N; Dell'Oglio P; Cucchiara V; Capogrosso P; Shariat SF; Damiano R; Salonia A; Montorsi F; Briganti A; Gallina A; Colombo R
    Eur J Surg Oncol; 2016 May; 42(5):735-43. PubMed ID: 26927300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of local recurrence after radical cystectomy in a contemporary series of patients with muscle-invasive bladder cancer.
    Cornu JN; Neuzillet Y; Hervé JM; Yonneau L; Botto H; Lebret T
    World J Urol; 2012 Dec; 30(6):821-6. PubMed ID: 22940772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical cystectomy for recurrent urothelial carcinoma after prior partial cystectomy: perioperative and oncologic outcomes.
    Mason RJ; Frank I; Bhindi B; Tollefson MK; Thompson RH; Karnes RJ; Tarrell R; Thapa P; Boorjian SA
    World J Urol; 2017 Dec; 35(12):1879-1884. PubMed ID: 28913657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Charlson comorbidity index predicts survival after disease recurrence in patients following radical cystectomy for urothelial carcinoma of the bladder.
    Mayr R; May M; Burger M; Martini T; Pycha A; Dechet C; Lodde M; Comploj E; Wieland WF; Denzinger S; Otto W; Aziz A; Fritsche HM; Gierth M
    Urol Int; 2014; 93(3):303-10. PubMed ID: 25139069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of clinical stage among patients with a complete pathologic response at radical cystectomy after neoadjuvant chemotherapy.
    Parker WP; Ho PL; Boorjian SA; Melquist JJ; Thapa P; Holzbeierlein JM; Frank I; Kamat AM; Lee EK
    World J Urol; 2016 Nov; 34(11):1561-1566. PubMed ID: 26943643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
    Tilki D; Shariat SF; Lotan Y; Rink M; Karakiewicz PI; Schoenberg MP; Lerner SP; Sonpavde G; Sagalowsky AI; Gupta A
    BJU Int; 2013 Jun; 111(8):1215-21. PubMed ID: 23181623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
    Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
    Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and outcomes of urethral recurrence of urinary bladder cancer in women after radical cystectomy and orthotopic neobladder: a series of 12 cases.
    Hrbáček J; Macek P; Ali-El-Dein B; Thalmann GN; Stenzl A; Babjuk M; Shaaban AA; Gakis G
    Urol Int; 2015; 94(1):45-9. PubMed ID: 25171129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.
    Kusaka A; Hatakeyama S; Hosogoe S; Hamano I; Iwamura H; Fujita N; Fukushi K; Narita T; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ito H; Yoshikawa K; Kawaguchi T; Ohyama C
    Med Oncol; 2017 May; 34(5):90. PubMed ID: 28397105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients.
    Kluth LA; Rieken M; Xylinas E; Kent M; Rink M; Rouprêt M; Sharifi N; Jamzadeh A; Kassouf W; Kaushik D; Boorjian SA; Roghmann F; Noldus J; Masson-Lecomte A; Vordos D; Ikeda M; Matsumoto K; Hagiwara M; Kikuchi E; Fradet Y; Izawa J; Rendon R; Fairey A; Lotan Y; Bachmann A; Zerbib M; Fisch M; Scherr DS; Vickers A; Shariat SF
    Eur Urol; 2014 Nov; 66(5):913-9. PubMed ID: 24331151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender-specific survival following radical cystectomy for pT4 bladder cancer.
    Kaushik D; Frank I; Eisenberg MS; Cheville JC; Tarrell R; Thapa P; Thompson RH; Boorjian SA
    World J Urol; 2014 Dec; 32(6):1433-9. PubMed ID: 24362884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram for predicting survival of postcystectomy recurrent urothelial carcinoma of the bladder.
    Nakagawa T; Taguchi S; Uemura Y; Kanatani A; Ikeda M; Matsumoto A; Yoshida K; Kawai T; Nagata M; Yamada D; Komemushi Y; Suzuki M; Enomoto Y; Nishimatsu H; Ishikawa A; Nagase Y; Kondo Y; Tanaka Y; Okaneya T; Hirano Y; Shinohara M; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
    Urol Oncol; 2017 Jul; 35(7):457.e15-457.e21. PubMed ID: 28110856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy.
    Linder BJ; Frank I; Cheville JC; Tollefson MK; Thompson RH; Tarrell RF; Thapa P; Boorjian SA
    Eur Urol; 2013 May; 63(5):839-45. PubMed ID: 23332883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of cancer-specific mortality after disease recurrence following radical cystectomy.
    Rink M; Lee DJ; Kent M; Xylinas E; Fritsche HM; Babjuk M; Brisuda A; Hansen J; Green DA; Aziz A; Cha EK; Novara G; Chun FK; Lotan Y; Bastian PJ; Tilki D; Gontero P; Pycha A; Baniel J; Mano R; Ficarra V; Trinh QD; Tagawa ST; Karakiewicz PI; Scherr DS; Sjoberg DD; Shariat SF;
    BJU Int; 2013 Mar; 111(3 Pt B):E30-6. PubMed ID: 22938654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis.
    Bruins HM; Aben KK; Arends TJ; van der Heijden AG; Witjes AJ
    Urol Oncol; 2016 Apr; 34(4):166.e1-6. PubMed ID: 26705102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.